TY - JOUR
T1 - Tetracistronic minigenomes elucidate a functional promoter for Ghana virus and unveils Cedar virus replicase promiscuity for all henipaviruses
AU - Haas, Griffin D.
AU - Kowdle, Shreyas
AU - Schmitz, Katharina S.
AU - Azarm, Kristopher D.
AU - Johnson, Kendra N.
AU - Klain, William R.
AU - Freiberg, Alexander N.
AU - Cox, Robert M.
AU - Plemper, Richard K.
AU - Lee, Benhur
N1 - Publisher Copyright:
© 2024 Haas et al.
PY - 2024/10
Y1 - 2024/10
N2 - Batborne henipaviruses, such as Nipah and Hendra viruses, represent a major threat to global health due to their propensity for spillover, severe pathogenicity, and high mortality rate in human hosts. Coupled with the absence of approved vaccines or therapeutics, work with the prototypical species and uncharacterized, emergent species is restricted to high biocontainment facilities. There is a scarcity of such specialized spaces for research, and often, the scope and capacity of research, which can be conducted at BSL-4, is limited. Therefore, there is a pressing need for innovative life-cycle modeling systems to enable comprehensive research within lower biocontainment settings. This work showcases tetracistronic, transcription, and replication-competent minigenomes for the Nipah, Hendra, and Cedar viruses, which encode viral proteins facilitating budding, fusion, and receptor binding. We validate the functionality of all encoded viral proteins and demonstrate a variety of applications to interrogate the viral life cycle. Notably, we found that the Cedar virus replicase exhibits remarkable promiscuity, efficientlydriving replication and transcription of minigenomes from all tested henipaviruses. We also apply this technology to Ghana virus (GhV), an emergent species that has so far not been isolated in culture. We demonstrate that the reported sequence of GhV is incomplete, but that this missing sequence can be substituted with analogous sequences from other henipaviruses. The use of our GhV system establishes the functionality of the GhV replicase and identifiestwo antivirals that are highly efficaciousagainst the GhV polymerase.
AB - Batborne henipaviruses, such as Nipah and Hendra viruses, represent a major threat to global health due to their propensity for spillover, severe pathogenicity, and high mortality rate in human hosts. Coupled with the absence of approved vaccines or therapeutics, work with the prototypical species and uncharacterized, emergent species is restricted to high biocontainment facilities. There is a scarcity of such specialized spaces for research, and often, the scope and capacity of research, which can be conducted at BSL-4, is limited. Therefore, there is a pressing need for innovative life-cycle modeling systems to enable comprehensive research within lower biocontainment settings. This work showcases tetracistronic, transcription, and replication-competent minigenomes for the Nipah, Hendra, and Cedar viruses, which encode viral proteins facilitating budding, fusion, and receptor binding. We validate the functionality of all encoded viral proteins and demonstrate a variety of applications to interrogate the viral life cycle. Notably, we found that the Cedar virus replicase exhibits remarkable promiscuity, efficientlydriving replication and transcription of minigenomes from all tested henipaviruses. We also apply this technology to Ghana virus (GhV), an emergent species that has so far not been isolated in culture. We demonstrate that the reported sequence of GhV is incomplete, but that this missing sequence can be substituted with analogous sequences from other henipaviruses. The use of our GhV system establishes the functionality of the GhV replicase and identifiestwo antivirals that are highly efficaciousagainst the GhV polymerase.
KW - antivirals
KW - emerging pathogens
KW - Ghana virus
KW - henipavirus
KW - high biocontainment
KW - minigenome
KW - Nipah virus
KW - paramyxovirus
KW - reverse genetics
KW - viral RNA dependent RNA polymerase
UR - http://www.scopus.com/inward/record.url?scp=85207598989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85207598989&partnerID=8YFLogxK
U2 - 10.1128/jvi.00806-24
DO - 10.1128/jvi.00806-24
M3 - Article
C2 - 39345144
AN - SCOPUS:85207598989
SN - 0022-538X
VL - 98
JO - Journal of virology
JF - Journal of virology
IS - 10
M1 - e00806-24
ER -